Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q4 2018 · 10-K
Revenue$340.38M$340.38M−8.0% vs Q4 2017 Net Income-$7.36M-$7.36MN/M vs Q4 2017 EPS Diluted-$0.36-$0.36N/M vs Q4 2017 Gross Profit$134,640,000−2.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$49,933,000−40.9% Free Cash Flowderived$32,270,000−47.8% Margins · derivedGross margin39.6%+2.4 pt vs Q4 2017
Operating margin-3.6%−14.8 pt vs Q4 2017
Net margin-2.2%−15.6 pt vs Q4 2017
ended Dec 31, 2018 · filed Mar 1, 2019 · 60 d after period end